Daily as of 3 Nov 16:00 ET
- Price
- below both $15.99 vs 50 $24.39 / 200 $26.83
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 24 Mar 2026 · projected 28 bars out · tested 1 bar
MLYS | Mineralys TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$15.99
+$0.44 (+2.83%)
Mineralys Therapeutics (MLYS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.
The 50 SMA has sat below the 200 on the daily since Mar 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- below both $15.96 vs 50 $21.43 / 200 $25.56
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 8 Oct 2026 · projected 24 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 8 Oct 2026 | 💀Death | 4-hour | 24 bars out | Not tested |
| 15 Sep 2026 | 🟨Golden | 4-hour | 13 bars out | 2 bar cross test |
| 24 Mar 2026 | 💀Death steep | daily | 28 bars out | 1 bar cross test |
| 16 Apr 2025 | 🟨Golden moderate | daily | 29 bars out | 1 bar cross test |
| 15 Jan 2025 | 💀Death | daily | 26 bars out | Not tested |
About MLYS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$24M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandmid